Literature DB >> 27785714

Endoluminal Treatments for Obesity and Related Hypertension: Updates, Review, and Clinical Perspective.

Courtney Cripps1, Mitchell Roslin2.   

Abstract

PURPOSE OF REVIEW: Obesity is a global epidemic that continues to grow and results in related conditions such as hypertension and diabetes despite established interventions, thus suggesting the importance of new technologies. RECENT
FINDINGS: Endoscopic interventions are vast in scope and effectiveness. Intra-gastric balloons appear to dominate the field at this time, but a recent FDA-approved technique, the Aspire device, may soon cause a shift in the treatment paradigm. Short-term studies demonstrate optimistic results, yet long-term studies have not been performed. In addition, complications from these procedures are severe, resulting in significant morbidity when they occur. Treatment of bariatric surgery complications with endoscopic techniques is an expanding field that relies heavily on new innovation. The next few years in bariatric endoscopy promise to be turbulent and controversial. Endoscopic procedures for obesity will undoubtedly increase but are anticipated to do so at a slower rate than many projects. Bariatric surgery complications will continue to be treated by endoscopic means, and optimization of these procedures is on the horizon. This review will provide those who treat obesity-related hypertension on the current state of bariatric endoluminal procedures.

Entities:  

Keywords:  Bariatric surgery; Endoluminal interventions; Obesity-related hypertension

Mesh:

Year:  2016        PMID: 27785714     DOI: 10.1007/s11906-016-0691-0

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  30 in total

1.  Degradation of five polyurethane gastric bubbles following in vivo use: SEC, ATR-IR and DSC studies.

Authors:  J G Dillon; M K Hughes
Journal:  Biomaterials       Date:  1992       Impact factor: 12.479

2.  A prospective assessment of the Garren-Edwards Gastric Bubble and bariatric surgery in the treatment of morbid obesity.

Authors:  D F Kirby; J B Wade; P R Mills; H J Sugerman; J M Kellum; A M Zfass; J V Starkey; R Birkenhauer; R M Hamer
Journal:  Am Surg       Date:  1990-10       Impact factor: 0.688

3.  Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner.

Authors:  Eduardo G H de Moura; Bruno C Martins; Guilherme S Lopes; Ivan R Orso; Suzana L de Oliveira; Manoel P Galvão Neto; Marco A Santo; Paulo Sakai; Almino C Ramos; Arthur B Garrido Júnior; Marcio C Mancini; Alfredo Halpern; Ivan Cecconello
Journal:  Diabetes Technol Ther       Date:  2011-09-20       Impact factor: 6.118

4.  Association between bariatric surgery and long-term survival.

Authors:  David E Arterburn; Maren K Olsen; Valerie A Smith; Edward H Livingston; Lynn Van Scoyoc; William S Yancy; George Eid; Hollis Weidenbacher; Matthew L Maciejewski
Journal:  JAMA       Date:  2015-01-06       Impact factor: 56.272

5.  Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve.

Authors:  Bryan J Sandler; Roberto Rumbaut; C Paul Swain; Gustavo Torres; Luis Morales; Lizcelly Gonzales; Sarah Schultz; Mark Talamini; Santiago Horgan
Journal:  Surg Endosc       Date:  2011-04-13       Impact factor: 4.584

6.  BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients.

Authors:  A Genco; T Bruni; S B Doldi; P Forestieri; M Marino; L Busetto; C Giardiello; L Angrisani; L Pecchioli; P Stornelli; F Puglisi; M Alkilani; A Nigri; N Di Lorenzo; F Furbetta; A Cascardo; M Cipriano; M Lorenzo; N Basso
Journal:  Obes Surg       Date:  2005-09       Impact factor: 4.129

7.  Surgical complications of the Garren-Edwards Gastric Bubble.

Authors:  K S Ulicny; S J Goldberg; W J Harper; J L Korelitz; P C Podore; R H Fegelman
Journal:  Surg Gynecol Obstet       Date:  1988-06

8.  Metabolic/bariatric surgery worldwide 2011.

Authors:  Henry Buchwald; Danette M Oien
Journal:  Obes Surg       Date:  2013-04       Impact factor: 4.129

Review 9.  ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies.

Authors:  Barham K Abu Dayyeh; Nitin Kumar; Steven A Edmundowicz; Sreenivasa Jonnalagadda; Michael Larsen; Shelby Sullivan; Christopher C Thompson; Subhas Banerjee
Journal:  Gastrointest Endosc       Date:  2015-07-29       Impact factor: 9.427

10.  Effects of bariatric surgery on incidence of obesity-related cancers: a meta-analysis.

Authors:  Xiang-wu Yang; Peng-zhou Li; Li-yong Zhu; Shaihong Zhu
Journal:  Med Sci Monit       Date:  2015-05-11
View more
  3 in total

1.  The dose-response analysis between BMI and common chronic diseases in northeast China.

Authors:  Jianxing Yu; Yuchun Tao; Jing Dou; Junsen Ye; Yaqin Yu; Lina Jin
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

2.  Association between Health Literacy and Prevalence of Obesity, Arterial Hypertension, and Diabetes Mellitus.

Authors:  Božica Lovrić; Harolt Placento; Nikolina Farčić; Metka Lipič Baligač; Štefica Mikšić; Marin Mamić; Tihomir Jovanović; Hrvoje Vidić; Sandra Karabatić; Sabina Cviljević; Lada Zibar; Ivan Vukoja; Ivana Barać
Journal:  Int J Environ Res Public Health       Date:  2022-07-24       Impact factor: 4.614

Review 3.  Diet, Lifestyle and Cardiovascular Diseases: Linking Pathophysiology to Cardioprotective Effects of Natural Bioactive Compounds.

Authors:  Javad Sharifi-Rad; Célia F Rodrigues; Farukh Sharopov; Anca Oana Docea; Aslı Can Karaca; Mehdi Sharifi-Rad; Derya Kahveci Karıncaoglu; Gözde Gülseren; Ezgi Şenol; Evren Demircan; Yasaman Taheri; Hafiz Ansar Rasul Suleria; Beraat Özçelik; Kadriye Nur Kasapoğlu; Mine Gültekin-Özgüven; Ceren Daşkaya-Dikmen; William C Cho; Natália Martins; Daniela Calina
Journal:  Int J Environ Res Public Health       Date:  2020-03-30       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.